Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Vasodilator-Stimulated Phosphoprotein Biomarkers Are Associated with Invasion and Metastasis in Colorectal Cancer.

Pitari GM, Cotzia P, Ali M, Birbe R, Rizzo W, Bombonati A, Palazzo J, Solomides C, Shuber AP, Sinicrope FA, Zuzga DS.

Biomark Cancer. 2018 Jun 5;10:1179299X18774551. doi: 10.1177/1179299X18774551. eCollection 2018.

2.

Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.

Bashir B, Merlino DJ, Rappaport JA, Gnass E, Palazzo JP, Feng Y, Fearon ER, Snook AE, Waldman SA.

Hum Pathol. 2019 May;87:103-114. doi: 10.1016/j.humpath.2018.11.032. Epub 2019 Feb 2.

PMID:
30716341
3.

Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas.

Pareja F, Geyer FC, Brown DN, Sebastião APM, Gularte-Mérida R, Li A, Edelweiss M, Da Cruz Paula A, Selenica P, Wen HY, Jungbluth AA, Varga Z, Palazzo J, Rubin BP, Ellis IO, Brogi E, Rakha EA, Weigelt B, Reis-Filho JS.

NPJ Breast Cancer. 2019 Jan 18;5:6. doi: 10.1038/s41523-018-0101-7. eCollection 2019.

4.

Environmental Benefits of Novel Nonhuman Food Inputs to Salmon Feeds.

Couture JL, Geyer R, Hansen JØ, Kuczenski B, Øverland M, Palazzo J, Sahlmann C, Lenihan H.

Environ Sci Technol. 2019 Feb 19;53(4):1967-1975. doi: 10.1021/acs.est.8b03832. Epub 2019 Jan 31.

PMID:
30653307
5.

Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast.

Vranic S, Palazzo J, Swensen J, Xiu J, Florento E, Gatalica Z.

Breast J. 2019 Jan;25(1):175-176. doi: 10.1111/tbj.13187. Epub 2018 Dec 18. No abstract available.

PMID:
30565349
6.

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.

Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H.

Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4.

PMID:
30528798
7.

Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score.

Jerevall PL, Brock J, Palazzo J, Wieczorek T, Misialek M, Guidi AJ, Wu Y, Erlander MG, Zhang Y, Schnabel CA, Goss PE, Horick N, Sgroi DC.

Breast Cancer Res Treat. 2019 Jan;173(2):375-383. doi: 10.1007/s10549-018-5013-6. Epub 2018 Oct 22.

PMID:
30350269
8.

A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer.

Ye Z, Wang C, Guo L, Palazzo JP, Han Z, Lai Y, Jiang J, Posey JA, Mallick AB, Li B, Jiang L, Yang H.

J Natl Compr Canc Netw. 2018 Oct;16(10):1183-1192. doi: 10.6004/jnccn.2018.7048.

PMID:
30323088
9.

Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.

Vranic S, Palazzo J, Sanati S, Florento E, Contreras E, Xiu J, Swensen J, Gatalica Z.

Clin Breast Cancer. 2019 Apr;19(2):131-136. doi: 10.1016/j.clbc.2018.09.001. Epub 2018 Sep 5.

10.

Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Pareja F, Brandes AH, Basili T, Selenica P, Geyer FC, Fan D, Da Cruz Paula A, Kumar R, Brown DN, Gularte-Mérida R, Alemar B, Bi R, Lim RS, de Bruijn I, Fujisawa S, Gardner R, Feng E, Li A, da Silva EM, Lozada JR, Blecua P, Cohen-Gould L, Jungbluth AA, Rakha EA, Ellis IO, Edelweiss MIA, Palazzo J, Norton L, Hollmann T, Edelweiss M, Rubin BP, Weigelt B, Reis-Filho JS.

Nat Commun. 2018 Aug 30;9(1):3533. doi: 10.1038/s41467-018-05886-y.

11.

Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.

Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H.

Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.

PMID:
30097435
12.

STAT6 expression in spindle cell lesions of the breast: An immunohistochemical study of 48 cases.

Magro G, Spadola S, Motta F, Palazzo J, Catalano F, Vecchio GM, Salvatorelli L.

Pathol Res Pract. 2018 Oct;214(10):1544-1549. doi: 10.1016/j.prp.2018.07.011. Epub 2018 Jul 17.

PMID:
30072169
13.

Utility of STAT6 and 13q14 deletion in the classification of the benign spindle cell stromal tumors of the breast.

Magro G, Angelico G, Righi A, Benini S, Salvatorelli L, Palazzo J.

Hum Pathol. 2018 Nov;81:55-64. doi: 10.1016/j.humpath.2018.06.015. Epub 2018 Jun 27.

PMID:
29940288
14.

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.

Geyer FC, Li A, Papanastasiou AD, Smith A, Selenica P, Burke KA, Edelweiss M, Wen HC, Piscuoglio S, Schultheis AM, Martelotto LG, Pareja F, Kumar R, Brandes A, Fan D, Basili T, Da Cruz Paula A, Lozada JR, Blecua P, Muenst S, Jungbluth AA, Foschini MP, Wen HY, Brogi E, Palazzo J, Rubin BP, Ng CKY, Norton L, Varga Z, Ellis IO, Rakha EA, Chandarlapaty S, Weigelt B, Reis-Filho JS.

Nat Commun. 2018 May 8;9(1):1816. doi: 10.1038/s41467-018-04128-5.

15.

Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.

Wei Q, Ye Z, Zhong X, Li L, Wang C, Myers RE, Palazzo JP, Fortuna D, Yan A, Waldman SA, Chen X, Posey JA, Basu-Mallick A, Jiang BH, Hou L, Shu J, Sun Y, Xing J, Li B, Yang H.

Ann Oncol. 2017 Sep 1;28(9):2135-2141. doi: 10.1093/annonc/mdx278.

16.

An miRNA Expression Signature for the Human Colonic Stem Cell Niche Distinguishes Malignant from Normal Epithelia.

Viswanathan V, Damle S, Zhang T, Opdenaker L, Modarai S, Accerbi M, Schmidt S, Green P, Galileo D, Palazzo J, Fields J, Haghighat S, Rigoutsos I, Gonye G, Boman BM.

Cancer Res. 2017 Jul 15;77(14):3778-3790. doi: 10.1158/0008-5472.CAN-16-2388. Epub 2017 May 9.

17.

Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience.

Nam K, Eisenbrey JR, Stanczak M, Sridharan A, Berger AC, Avery T, Palazzo JP, Forsberg F.

Radiology. 2017 Oct;285(1):53-62. doi: 10.1148/radiol.2017161683. Epub 2017 May 3.

18.

MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer.

Johnson JM, Cotzia P, Fratamico R, Mikkilineni L, Chen J, Colombo D, Mollaee M, Whitaker-Menezes D, Domingo-Vidal M, Lin Z, Zhan T, Tuluc M, Palazzo J, Birbe RC, Martinez-Outschoorn UE.

Front Cell Dev Biol. 2017 Apr 3;5:27. doi: 10.3389/fcell.2017.00027. eCollection 2017.

19.

MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation.

Fortuna D, Boman B, O'Neill R, Palazzo J.

Hum Pathol. 2017 May;63:177-183. doi: 10.1016/j.humpath.2017.02.020. Epub 2017 Mar 14.

PMID:
28302537
20.

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.

Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H.

Breast Cancer Res Treat. 2017 Jan;161(1):83-94. doi: 10.1007/s10549-016-4026-2. Epub 2016 Oct 22.

PMID:
27771841
21.

Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.

Joneja U, Vranic S, Swensen J, Feldman R, Chen W, Kimbrough J, Xiao N, Reddy S, Palazzo J, Gatalica Z.

J Clin Pathol. 2017 Mar;70(3):255-259. doi: 10.1136/jclinpath-2016-203874. Epub 2016 Aug 16.

22.

Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less.

Toss A, Palazzo J, Berger A, Guiles F, Sendecki JA, Simone N, Anne R, Avery T, Jaslow R, Lazar M, Tsangaris T, Cristofanilli M.

Breast. 2016 Oct;29:223-30. doi: 10.1016/j.breast.2016.07.023. Epub 2016 Aug 6.

PMID:
27506636
23.

Solitary Fibrous Tumor at the Anal Margin.

Krementz N, Terlizzi J, Casey J, Palazzo J, Isenberg G.

Am Surg. 2016 Jul;82(7):e135-7. No abstract available.

PMID:
27457836
24.

Pathologic Spectrum of Secretory and Mucinous Breast Lesions.

Toll A, Joneja U, Palazzo J.

Arch Pathol Lab Med. 2016 Jul;140(7):644-50. doi: 10.5858/arpa.2015-0250-RA. Review.

PMID:
27362569
25.

Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.

Simone BA, Dan T, Palagani A, Jin L, Han SY, Wright C, Savage JE, Gitman R, Lim MK, Palazzo J, Mehta MP, Simone NL.

Cell Cycle. 2016 Sep;15(17):2265-74. doi: 10.1080/15384101.2016.1160982. Epub 2016 Mar 30.

26.

Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?

Tatarian T, Sokas C, Rufail M, Lazar M, Malhotra S, Palazzo JP, Hsu E, Tsangaris T, Berger AC.

Ann Surg Oncol. 2016 Aug;23(8):2501-7. doi: 10.1245/s10434-016-5182-7. Epub 2016 Mar 9.

PMID:
26960929
27.

Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.

Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H.

Gastroenterology. 2016 May;150(5):1135-1146. doi: 10.1053/j.gastro.2016.01.030. Epub 2016 Feb 2.

28.

Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.

Mardekian SK, Bombonati A, Palazzo JP.

Hum Pathol. 2016 Mar;49:114-23. doi: 10.1016/j.humpath.2015.11.003. Epub 2015 Nov 17. Review.

PMID:
26826418
29.

Solitary fibrous tumor of the breast: report of a case with emphasis on diagnostic role of STAT6 immunostaining.

Magro G, Angelico G, Leone G, Palazzo J.

Pathol Res Pract. 2016 May;212(5):463-7. doi: 10.1016/j.prp.2015.12.013. Epub 2015 Dec 31.

PMID:
26778386
30.

Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.

Gatalica Z, Vranic S, Ghazalpour A, Xiu J, Ocal IT, McGill J, Bender RP, Discianno E, Schlum A, Sanati S, Palazzo J, Reddy S, Pockaj B.

Oncotarget. 2016 Jan 12;7(2):1707-16. doi: 10.18632/oncotarget.6421.

31.

Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.

Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M.

Breast Cancer Res Treat. 2015 Dec;154(3):563-71. doi: 10.1007/s10549-015-3636-4. Epub 2015 Nov 16.

PMID:
26573830
32.

Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies.

Telonis AG, Loher P, Honda S, Jing Y, Palazzo J, Kirino Y, Rigoutsos I.

Oncotarget. 2015 Sep 22;6(28):24797-822. doi: 10.18632/oncotarget.4695.

33.

The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study.

Lai Y, Ye Z, Civan JM, Wang C, Cristofanilli M, Mu Z, Austin L, Palazzo JP, Myers RE, Yang H.

Breast Cancer Res Treat. 2015 Sep;153(2):407-16. doi: 10.1007/s10549-015-3532-y. Epub 2015 Aug 12.

PMID:
26264468
34.

Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.

Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, Imoto I, Rigoutsos I, Kirino Y.

Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3816-25. doi: 10.1073/pnas.1510077112. Epub 2015 Jun 29.

35.

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.

Gatalica Z, Bilalovic N, Palazzo JP, Bender RP, Swensen J, Millis SZ, Vranic S, Von Hoff D, Arceci RJ.

Oncotarget. 2015 Aug 14;6(23):19819-25.

36.

Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables.

Wang C, Civan J, Lai Y, Cristofanilli M, Hyslop T, Palazzo JP, Myers RE, Li B, Ye Z, Zhang K, Xing J, Yang H.

Cancer Causes Control. 2015 Jan;26(1):45-56. doi: 10.1007/s10552-014-0481-4. Epub 2014 Oct 31.

PMID:
25359303
37.

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.

Fernandez SV, Bingham C, Fittipaldi P, Austin L, Palazzo J, Palmer G, Alpaugh K, Cristofanilli M.

Breast Cancer Res. 2014 Oct 9;16(5):445. doi: 10.1186/s13058-014-0445-3.

38.

Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.

Lai Y, Palazzo JP, Cristofanilli M, Hyslop T, Civan J, Avery T, Myers RE, Li B, Ye Z, Xing J, Yang H.

Breast Cancer Res Treat. 2014 Nov;148(1):175-85. doi: 10.1007/s10549-014-3152-y. Epub 2014 Sep 27.

PMID:
25261294
39.

Everything changes: successful integration of any type requires leadership, transparency.

Palazzo JM.

MGMA Connex. 2014 Feb;14(2):39-40. No abstract available.

PMID:
25174096
40.

Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers.

Wan S, Lai Y, Myers RE, Li B, Palazzo JP, Burkart AL, Chen G, Xing J, Yang H.

BMC Cancer. 2013 Jul 10;13:340. doi: 10.1186/1471-2407-13-340.

41.

Caloric restriction augments radiation efficacy in breast cancer.

Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, Jin L, Champ CE, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell RG, Mitchell JB, Lisanti MP, Simone NL.

Cell Cycle. 2013 Jun 15;12(12):1955-63. doi: 10.4161/cc.25016. Epub 2013 May 21.

42.

Impact of Oncotype DX on treatment decisions in ER-positive, node-negative breast cancer with histologic correlation.

Biroschak JR, Schwartz GF, Palazzo JP, Toll AD, Brill KL, Jaslow RJ, Lee SY.

Breast J. 2013 May-Jun;19(3):269-75. doi: 10.1111/tbj.12099.

PMID:
23614365
43.

Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients.

Ye Z, Palazzo JP, Lin L, Lai Y, Guiles F, Myers RE, Han J, Xing J, Yang H.

J Gastroenterol Hepatol. 2013 Sep;28(9):1469-75. doi: 10.1111/jgh.12237.

44.

Acinar cell cystadenoma of the pancreas: report of three cases and literature review.

Wolf AM, Shirley LA, Winter JM, Prestipino AJ, Palazzo JP, Yeo CJ, Lavu H.

J Gastrointest Surg. 2013 Jul;17(7):1322-6. doi: 10.1007/s11605-013-2199-0. Epub 2013 Apr 19. Review.

PMID:
23605178
45.

Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients.

Wan S, Lai Y, Myers RE, Li B, Hyslop T, London J, Chatterjee D, Palazzo JP, Burkart AL, Zhang K, Xing J, Yang H.

J Gastrointest Cancer. 2013 Sep;44(3):293-304. doi: 10.1007/s12029-013-9491-9.

46.

Boerhaave's syndrome as an initial presentation of eosinophilic esophagitis: a case series.

Jackson WE, Mehendiratta V, Palazzo J, Dimarino AJ, Quirk DM, Cohen S.

Ann Gastroenterol. 2013;26(2):166-169.

47.

Tricuspid valve injury after heart transplantation due to endomyocardial biopsy: an analysis of 3550 biopsies.

Fiorelli AI, Coelho GH, Aiello VD, Benvenuti LA, Palazzo JF, Santos Júnior VP, Canizares B, Dias RR, Stolf NA.

Transplant Proc. 2012 Oct;44(8):2479-82. doi: 10.1016/j.transproceed.2012.07.024.

PMID:
23026624
48.

Comparative analysis of the complications of 5347 endomyocardial biopsies applied to patients after heart transplantation and with cardiomyopathies: a single-center study.

Fiorelli AI, Benvenuti L, Aielo V, Coelho AQ, Palazzo JF, Rossener R, Barreto AC, Mady C, Bacal F, Bocchi E, Stolf NA.

Transplant Proc. 2012 Oct;44(8):2473-8. doi: 10.1016/j.transproceed.2012.07.023.

PMID:
23026623
49.

Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.

Schwartz GF, Bartelink H, Burstein HJ, Cady B, Cataliotti L, Fentiman IS, Holland R, Hughes KS, Masood S, McCormick B, Palazzo JA, Pressman PI, Reis-Filho J, Pusztai L, Rutgers EJ, Seidman AD, Solin LJ, Sparano JA.

Breast J. 2012 Jul-Aug;18(4):303-11. doi: 10.1111/j.1524-4741.2012.01264.x.

PMID:
22759093
50.

A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics.

Vranic S, Bender R, Palazzo J, Gatalica Z.

Hum Pathol. 2013 Mar;44(3):301-9. doi: 10.1016/j.humpath.2012.01.002. Epub 2012 Apr 18. Review.

PMID:
22520948

Supplemental Content

Loading ...
Support Center